导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 16.23% | 160/249 |
| 近一周 | -2.09% | 104/276 |
| 近一月 | 0.44% | 44/275 |
| 近一季 | 3.06% | 32/271 |
| 近半年 | 13.76% | 26/262 |
| 近一年 | 10.15% | 179/249 |
| 近两年 | 43.05% | 70/206 |
| 近三年 | 108.44% | 19/147 |
| 成立以来 | 541.41% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-8.33% 278/341 |
15.14% 99/349 |
8.62% 162/355 |
- - |
| 2024 | 21.60% 94/330 |
8.01% 71/280 |
7.05% 82/310 |
1.50% 223/319 |
3.62% 110/330 |
| 2023 | 52.12% 19/276 |
20.26% 1/205 |
14.37% 40/230 |
-3.24% 68/262 |
14.31% 20/276 |
| 2022 | -34.18% 145/202 |
-9.15% 75/153 |
-22.65% 149/164 |
-4.99% 66/189 |
-1.43% 164/202 |
| 2021 | 26.34% 20/151 |
1.43% 160/312 |
11.21% 48/328 |
0.73% 65/358 |
11.19% 19/151 |
| 2020 | 49.50% 3/104 |
-9.12% 111/280 |
29.27% 41/295 |
12.71% 26/299 |
12.89% 76/305 |
| 2019 | 36.20% 13/89 |
15.57% 47/258 |
4.10% 51/268 |
1.02% 111/253 |
12.06% 35/266 |
| 2018 | -1.59% 20/80 |
- - |
- - |
- - |
-15.97% 179/241 |
| 2017 | 29.39% 10/69 |
- - |
- - |
- - |
- - |
| 2016 | 2.66% 37/59 |
- - |
- - |
- - |
- - |
| 2015 | 6.08% 11/49 |
- - |
- - |
- - |
- - |
| 2014 | 16.29% 9/99 |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 嘉实标普生物科技精选行业ETF(QDII) | 1.2816 | 30.30% |
| 易方达标普生物科技美元汇A | 0.2448 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2415 | 28.01% |
| 易方达标普生物科技人民币A | 1.7298 | 27.30% |
| 易方达标普生物科技人民币C | 1.7060 | 27.21% |
| 汇添富纳斯达克生物科技ETF(QDII) | 1.4679 | 19.43% |
| 广发生物科技指数美元(QDII)A | 0.2092 | 18.59% |
| 广发生物科技指数美元(QDII)C | 0.2058 | 18.41% |
| 广发生物科技指数人民币(QDII)A | 1.4780 | 17.80% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现钞 | 1.3491 | 17.75% |
| 华安纳斯达克100ETF联接(QDII)A美元现汇 VS. 华宝标普油气上游股票人民币A(162411) |